- Home
- CRVS vs ZUMZ Comparison
CRVS vs ZUMZ Comparison
Compare CRVS & ZUMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- ZUMZ
- Stock Information
- Founded
- CRVS 2014
- ZUMZ 1978
- Country
- CRVS United States
- ZUMZ United States
- Employees
- CRVS N/A
- ZUMZ N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- ZUMZ Clothing/Shoe/Accessory Stores
- Sector
- CRVS Health Care
- ZUMZ Consumer Discretionary
- Exchange
- CRVS Nasdaq
- ZUMZ Nasdaq
- Market Cap
- CRVS 257.0M
- ZUMZ 274.4M
- IPO Year
- CRVS 2016
- ZUMZ 2005
- Fundamental
- Price
- CRVS $3.21
- ZUMZ $15.30
- Analyst Decision
- CRVS Strong Buy
- ZUMZ Hold
- Analyst Count
- CRVS 5
- ZUMZ 2
- Target Price
- CRVS $12.63
- ZUMZ $22.00
- AVG Volume (30 Days)
- CRVS 704.3K
- ZUMZ 423.0K
- Earning Date
- CRVS 05-05-2025
- ZUMZ 03-13-2025
- Dividend Yield
- CRVS N/A
- ZUMZ N/A
- EPS Growth
- CRVS N/A
- ZUMZ N/A
- EPS
- CRVS N/A
- ZUMZ N/A
- Revenue
- CRVS N/A
- ZUMZ $889,202,000.00
- Revenue This Year
- CRVS N/A
- ZUMZ $3.43
- Revenue Next Year
- CRVS N/A
- ZUMZ $1.97
- P/E Ratio
- CRVS N/A
- ZUMZ N/A
- Revenue Growth
- CRVS N/A
- ZUMZ 1.57
- 52 Week Low
- CRVS $1.30
- ZUMZ $12.67
- 52 Week High
- CRVS $10.00
- ZUMZ $31.37
- Technical
- Relative Strength Index (RSI)
- CRVS 29.29
- ZUMZ 54.82
- Support Level
- CRVS $3.06
- ZUMZ $14.03
- Resistance Level
- CRVS $3.45
- ZUMZ $15.66
- Average True Range (ATR)
- CRVS 0.37
- ZUMZ 0.84
- MACD
- CRVS -0.10
- ZUMZ 0.13
- Stochastic Oscillator
- CRVS 8.77
- ZUMZ 84.94
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers, and autoimmune diseases. The company's primary product candidate is Soquelitinib (CPI-818), an oral, small-molecule drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase). The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About ZUMZ Zumiez Inc.
Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.